Drugs Market Overview
Cancer is a chronic
disease group characterized by uncontrolled harmful cell growth. The most
common types of cancer are breast cancer, lung cancer, colorectal cancer,
cervical cancer, and thyroid cancer. The three main types of drugs used for
cancer are cytotoxic drugs, targeted drugs, and hormonal drugs, depending on
their mechanism of action. Due to increased drug approvals and the advent of
bio-similar drugs for cancer treatment, the Global Oncology Drug Market has
seen tremendous growth in the recent past. Increasing spending on cancer
treatment has also led to increased research and development efforts to develop
new, highly effective, and least side-effect cancer drugs.
Drugs Market Outlook and Trends
The global market for
Oncology/Cancer Drugs is anticipated to expand at a 7.2% CAGR during the
projection period. An increase in the incidence of cancer over the world and a
significant increase in government healthcare outlay facilitate growth in the
Global Market for Oncology/Cancer Drugs. An increase in the number of pipeline
drugs and untapped potential combined with rising alliances among
pharmaceutical companies offer lucrative opportunities to the market players in
the industry, particularly in emerging countries. Besides, the rising geriatric
population and cancer-causing factors, as well as the high probability of
cancer cases in emerging economies, induce the demand for cancer-treating
drugs. The market is expected to witness substantial growth during the
projection period due to the factors mentioned above. However, adverse
drug-related effects hinder the growth of the market.
Rising incidence of
cancer cases across the globe
The escalating cases of
cancer across the globe are attributed to several factors, such as the growing
ageing population, as well as the thriving prevalence of specific cancer causes
linked to social and economic development. In fast-growing economies, the shift
has been noticed from poverty-related cancers and infections to
lifestyle-related cancers. It directly drives substantial demand for oncology
drugs in the global market with significant growth.
Need for Innovative Drugs
and Target Groups
organizations are involved in the development of drugs that target cancer cells
directly and help destroy them. R & D and novel drugs play a crucial role
in the growth of the Global Market for Oncology/Cancer Drugs. Also, the
emphasis on biological therapy has recently brought massive revenues to the global
market for oncology/cancer drugs.
associated with the use of cancer drugs
Despite the improved
efficacy and enhanced survival offered by modern treatments, the side effects
and long-term sequel of anti-cancer chemotherapy remain a significant concern
for both patients and medical professionals.
Drugs Market Segmentation
By Drug Class Type
Targeted therapy and
Chemotherapy segments together accounted for nearly three-fourths of total
market share in 2019 based on drug class type, and are expected to maintain
dominance in the cancer drug industry over the forecast period. Conversely, the
section of immunotherapy is predicted to be a witness of lucrative growth due
to higher survival rates and use-related relief.
Based on the indication,
it is estimated that the lung cancer segment would record a significant rate of
growth from 2020 to 2026 due to a considerable increase in the prevalence of
cancer worldwide. On the other hand, the other segments such as Kidney, Breast,
and Prostate cancer together have contributed to the largest share of total
market share in 2019 and, are projected to continue to lead during the forecast
Drugs Market: Regional insights
Due to the high adoption
rate of cancer drugs, North America was the leading contributor to the
worldwide market in 2019 and is expected to maintain the same because of
massive healthcare development during the projection period. However,
Asia-Pacific is expected to grow at the highest rate due to rising disposable
income, research, development & innovation activities, and awareness of
various cancers during the forecast period from 2019 to 2026. Due to a vast
population base and modern health care facilities, North America and Europe
accounted for almost three-fourths of total market share in 2019 and, will
register substantial growth by 2026 due to the increased awareness of advanced
therapies, growth in cancer cases led by unhealthy lifestyle and easy access of
premiere chemotherapy treatments.
The major companies
operating in this market are AbbVie Inc., Astellas
Pharma, Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene
Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global
Services, LLC,), Merck & Co., Inc., Novartis AG, Pfizer Inc. and Other
Scope of the Report
data – 2016-2018
Base Year –
2020 – 2026
Revenue in USD
U.S, Canada, Germany, UK,
France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South
Korea UAE, South Africa, Saudi Arabia.
By Class Type, By Indication and By Region
Inc., Astellas Pharma, Inc., AstraZeneca PLC, Bristol-Myers Squibb Company,
Celgene Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson
(Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, Pfizer
Inc. and Other Prominent Players
other prominent players.
By Class Type
Ø Targeted Therapy
Ø Immunotherapy (Biologic Therapy)
Ø Hormonal Therapy
Ø Lung Cancer
Ø Stomach Cancer
Ø Colorectal Cancer
Ø Breast Cancer
Ø Prostate Cancer
Ø Liver Cancer
Ø Esophagus Cancer
Ø Cervical Cancer
Ø Kidney Cancer
Ø Bladder Cancer
Ø Other Cancers
Ø North America
Ø Asia Pacific (APAC)
Ø Latin America
Ø Middle East & Africa
The objective of the Study:
analyze and estimate the Global Oncology/Cancer Drugs Market size, in terms of
examine the market segmentation carefully and estimate the market size, in
terms of value, based on the region by segmenting the Global Oncology/Cancer
Drugs Market into five regions, namely, North America, Europe, Asia Pacific,
Rest of the World and their leading countries.
outline, categorize and project the Global Oncology/Cancer Drugs Market based
on Class Type, Indication and Region.
examine competitive developments in product, therapies and indication segments
as well as cancer types within the Global Oncology/Cancer Drugs Market.
highlight market dynamics such as drivers, restraints, opportunities, and
challenges and their impact.
Ø To provide
a detailed competitive landscape, including major players, their strategic
profiles, and market shares.
Business Questions Answered by the Report:
Ø How will the market drivers, restraints, and opportunities
affect the market dynamics?
Ø What will be the market size in terms of value and volume and
market statistics with a detailed classification?
Ø Which segment dominates the market or region, and which one will
be the fastest-growing, and why?
Ø Who are the key players in the market, and what is their share?
Ø What is the strategy adopted by key players, and how does it
affect the existing and new players?
Customization Scope for the Client:
Client satisfaction is our first and last priority, and that is
why BlueWeave Consulting offers customization as per client’s specific needs.
The following customization options are available for the report:
Ø Additional Company Information
Ø Detail Analysis of five additional companies
Ø Additional country analysis
Ø Detailed segment analysis